Searchable abstracts of presentations at key conferences in endocrinology

ea0035p956 | Steroid metabolism and action | ECE2014

Profiling of neuroactive steroids, their precursors and metabolites in patients suffering from multiple sclerosis

Kancheva Radmila , Hill Martin , Kancheva Lyudmila , Velikova Marta , Pavelcova Miluse , Starka Luboslav , Havrdova Eva

Some steroids modulate the permeability of ionotropic receptors on cell membranes and therefore may activate or inhibit neuronal activity depending on the steroid structure. These neuroactive steroids (NAS) exert neuroprotective effects like the neuronal remyelination.Multiple sclerosis (MS) is the most common cause of neurological disability in young adults. Therefore, the authors have followed the neuroprotective, GABAergic, glycinergic, glutamatergic ...

ea0099ep770 | Pituitary and Neuroendocrinology | ECE2024

Neuroprotective steroids in patients with multiple sclerosis

Kančeva Radmila , Hill Martin , Velikova Marta , Kancheva Lyudmila , Včelak Josef , Ampapa Radek , Žido Michal , Štětkařova Ivana , Libertinova Anna , Havrdova - Kubala Eva

Multiple sclerosis (MS) is a common inflammatory autoimmune and demyelinating disease of the central nervous system (CNS) that compromises health and leads to disability. Sex differences in the prevalence and progression of MS suggest the involvement of sex steroids in the pathophysiology of MS. In late pregnancy, at the highest levels of progesterone and estradiol, the number of relapses decreases and increases again after delivery due to changes in steroid levels. In additio...